Strive Financial Group’s Merck MRK Stock Holding History

Strive Financial Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Buy	82 +1	+1%	+$117	﹤0.01%	441
2026 Q1	$10K	Hold	81	–	–	0.01%	419
2025 Q4	$8.53K	Buy	+81	New	+$7.6K	﹤0.01%	406

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strive Financial Group's MRK Position: Q2 2026 in Review

Strive Financial Group increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $117 and bringing the position to 82 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Strive Financial Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Strive Financial Group held 82 shares of Merck worth $10.5K as of Q2 2026.
Strive Financial Group bought 1 Merck share in Q2 2026, an estimated $117.
Merck made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #441 holding.
Strive Financial Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.